| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |